Klümper, N., Tran, N. K., Zschäbitz, S., Hahn, O., Büttner, T., Roghmann, F., . . . Eckstein, M. (2024). NECTIN4 amplification is frequent in solid tumors and predicts enfortumab vedotin response in metastatic urothelial cancer. Journal of clinical oncology, 42(20), . https://doi.org/10.1200/JCO.23.01983
Chicago-Zitierstil (17. Ausg.)Klümper, Niklas, et al. "NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer." Journal of Clinical Oncology 42, no. 20 (2024). https://doi.org/10.1200/JCO.23.01983.
MLA-Zitierstil (9. Ausg.)Klümper, Niklas, et al. "NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer." Journal of Clinical Oncology, vol. 42, no. 20, 2024, https://doi.org/10.1200/JCO.23.01983.